Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1986-12-24
1989-05-30
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 21, 530387, 530414, 530833, A61K 39395
Patent
active
048349747
ABSTRACT:
A dry, immunologically active filtered product is produced through the controlled one or two stage ultrafiltration of liquid whey containing immunologically active immunoglobulin (Ig). When a predetermined quantity of the filtered product with an active Ig concentration of at least about seven percent of total solids is fed to newborn calves, the product functions as a substitute for natural colostrum, providing both temporary passive immunity as well as initiation of the active immune system of the animal. Disease resistance and growth rate in animals including humans is enhanced by oral administration of the filtered product. The immunological properties of the filtered product result from the presence of substantially enhanced concentrations of active Ig as well as other immunologically active whey components in comparison to the immunologically ineffective concentrations of these materials in the liquid whey ultrafiltration feedstock.
REFERENCES:
patent: 3376198 (1968-04-01), Peterson et al.
patent: 3487064 (1969-12-01), Swanson et al.
patent: 3547900 (1970-12-01), Dienst et al.
patent: 3687682 (1982-08-01), Scheder
patent: 3687928 (1972-08-01), Brouwer et al.
patent: 3707770 (1978-01-01), Timmins et al.
patent: 3791283 (1984-02-01), Moreno et al.
patent: 3930039 (1975-12-01), Kiupers
patent: 3969336 (1976-07-01), Criswell
patent: 3969337 (1976-07-01), Lauer et al.
patent: 3975517 (1976-08-01), Wilson
patent: 4018752 (1977-04-01), Buhler et al.
patent: 4028317 (1977-06-01), Chang
patent: 4042576 (1977-08-01), Eustache
patent: 4051235 (1977-09-01), Plymate
patent: 4100149 (1978-07-01), Meiller et al.
patent: 4229342 (1980-10-01), Mirabel
patent: 4265294 (1981-05-01), Buhler et al.
patent: 4376072 (1983-03-01), Connolly
patent: 4377569 (1983-03-01), Plymate
patent: 4402938 (1983-09-01), Collins et al.
patent: 4436658 (1984-03-01), Peyrouset et al.
patent: 4485040 (1984-11-01), Roger et al.
patent: 4490290 (1984-12-01), Gani et al.
patent: 4644056 (1987-02-01), Kothe et al.
patent: 4784850 (1988-11-01), Abraham
Physiological Effects of the Colostral Peptide, Colostrokinin, and Inanition on Immunoglobulin Absorption and Adrenal/Thyroid Response in the Bovine Neonate, T. G. Schlagheck, A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in the Graduate College of the University of Arizona (1983).
The Effects of Passive Immunity on Growth and Mortality in the Dairy Heifer, J. D. Robison, A 1984 Dissertation Submitted in Partial Fulfullment of the Requirement for the Degree of Doctor of Philosophy in the Graduate College of the University of Arizona.
Characterization of Monoclonal Antibodies to Bovine IgGl, W. A. Fleenor, D. O. Lucas, G. H. Stott and A. J. Guidry, Veterinary Immunology and Immunopathology, 6(1984) 365-378 Elsevier Science Publishers B. V., Amsterdam-Printed in the Netherlands.
Colostral Immunoglobulin Absorption Linearly Related to Concentration for Calves, G. H. Stott and A. Fellah, Dept. of Animal Science, U. of A., 1983, J. Dairy Sci 66: 1319-1328.
Quantification of Bovine IgG, IgM and IgA Antibodies to Clostridium Perfringens B--Toxin by Enzyme Immunoassay I. Preparturient Immunization for Enhancement of Passive Transfer of Immunity, W. A. Fleenor and G. H. Stott, Dept. of Animal Science, U. of A., Veterinary Immunology and Immunopathology, 4 (1983) 579-591, Elsevier Science Publishers B. V., Amsterdam--Printed in the Netherlands.
Colostral Immunoglobulin Concentration in Two Fractions of First Milking Postpartum and Five Additional Milkings, G. H. Stott, W. A. Fleenor and W. C. Kleese, Dept. of Animal Science, U. of A., 1981, J. Dairy Sci 64: 459-465.
Effect of Suckling Followed by Bottle Feeding Colostrum on Immunoglobulin Absorption and Calf Survival, T. J. Brignole and G. H. Stott, Dept. of Animal Sciences, U. of A., 1980, J. Dairy Sci 63: 451-456.
Colostral Immunoglobulin Transfer in Calves-The Rate of Absorption, G. H. Stott, D. Marx, B. E. Menefee and G. T. Nightengale, Dept. of Animal Sciences and Center for Quantitative Studies, U. of A., 1979, J. Dairy Sci 62: 1766-1773.
Nutritional and Biochemical Studies of Whey Products, E. Forsum and L. Hambraeus, Institute of Nutrition, University of Uppsala, J. Dairy Sci 60: 370-377.
Use of Ultrafiltration/Reverse Osmosis Systems for the Concentration and Fractionation of Whey, R. I. Fenton-May and C. G. Hill, Jr., Dept. of Chemical Engineering, Univ. of Madison Wisconsin and C. H. Amundson, Dept. of Food Science, Univ. of Madison, Wisconsin 14-Journal of Food Science--vol. 36 (1971).
Nomenclature of Proteins of Cow's Milk: Fifth Revision, W. N. Eigel, J. E. Butler, C. A. Ernstrom, H. M. Farrell, Jr., V. R. Harwalker, R. Jenness, R. McL. Whitney, 1984, J. Dairy Sci 67: 1599-1631.
Antibody to Human Rotavirus in Cow's Milk, R. H. Yolken, MD, G. A. Losonsky, MD, S. Vonderfecht, DVM, PhD, Flora Leister, BA, and Siok-Bi Wee, MS, The New England Journal of Medicine, Mar. 7, 1985.
Preparation of Bovine Immunoglobulins and Free Secretory Component and Their Specific Antisera, J. E. Butler and C. F. Maxwell, J. Dairy Sci 55:151.
Advertisement: The Genecol 99 Story . . . "How to Reduce the Death Losses Caused by E. coli Scours".
Protection of Calves Against Fatal Enteric Colibacillosis by Orally Administered Escherichia Coli K 99-Specific Monoclonal Antibody, D. M. Sherman, D. D. Acres, P. L. Sadowski, J. A. Spring, B. Bray, T. J. G. Raybould and C. C. Muscoplat, Infection and Immunity (Nov. 1983) 42: 563-658.
Trends in W. Fractionation and Utilization Global Perspective, Roger R. Zall, Dept. of Food Science, 1984, J. Dairy Sci 67: 2621-2629.
Review of Processes and Products for Utilization of Lactose in Deproteinated Milk Serum, P. G. Hobman, New Zealand Dairy Research Institute, 1984, J. Dairy Sci 67: 2630-2653.
Whey Protein Recovery Processes and Products, M. E. Matthews, Rangitaiki Plains Dairy Company, 1984, J. Dairy Sci 67: 2680-2692.
Symposium: Assessing Functionality of Whey Proteins--Critical Aspects in Development of Whey Protein Concentrate, Nicholas Melochouris, Stauffer Chemical Company, 1984, J. Dairy Sci. 67: 2693-2700.
Effects of Various Heat Treatments on Structure and Solubility of Whey Proteins, J. N. deWit and G. Klarenbeek, Netherlands Institute for Dairy Research, 1984, J. Dairy Sci 67: 2701-2710.
Lucas David O.
Stott Gerald H.
Protein Technologies Inc.
Schain Howard E.
LandOfFree
Immunologically active whey fraction and recovery process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunologically active whey fraction and recovery process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunologically active whey fraction and recovery process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2151253